NNM Securities
ABOUT US
SERVICES
EQUITY
COMMODITY
CURRENCY
DERIVATIVES
MUTUAL FUND
ADVISORY
FINANCING
MARKET INFO
EQUITY
DERIVATIVES
IPO
MUTUAL FUNDS
CURRENCY
COMMODITIES
RESEARCH
CONTACT US
LOGIN
Gallery
Open Account Meon
Open Account
Partner Us
Downloads
COMPANY
EQUITY
DERIVATIVES
IPO
MUTUAL FUNDS
CURRENCY
COMMODITIES
more from company profile
General
Smart Quotes
Company Information
Comparison
Company News
Financials
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratios
Cash Flow
Holdings
Share Holdings
MF Holdings
Digital Reports
Corp Actions
Board Meeting
Book Closure
Bonus Issues
Dividend Details
Price Info
Share Price
Historical Volume
Deliverable Volume
Bulk Deals
Block Deals
Price Charts
Home
Market Info
Company Profile
Financial Ratios
Financial Ratios
PROCTER & GAMBLE HEALTH LTD.
NSE :
PGHL
BSE :
500126
ISIN CODE :
INE199A01012
Industry :
Pharmaceuticals & Drugs
House :
Merck - MNC
BSE
4700.00
-32.55 (-0.69 %)
PREV CLOSE (
)
4732.55
OPEN PRICE (
)
4733.20
BID PRICE (QTY)
0.00 (0)
OFFER PRICE (QTY)
0.00 (0)
VOLUME
972
TODAY'S LOW / HIGH (
)
4689.25
4776.15
52 WK LOW / HIGH (
)
4487.5
5640
NSE
4709.90
-28.9 (-0.61 %)
PREV CLOSE(
)
4738.80
OPEN PRICE (
)
4738.80
BID PRICE (QTY)
4709.90 (14)
OFFER PRICE (QTY)
0.00 (0)
VOLUME
72052
TODAY'S LOW / HIGH(
)
4698.10
4785.00
52 WK LOW / HIGH (
)
4492.8
5642.85
Consolidated
Standalone
Select year
Jun2023
Jun2022
Jun2021
Jun2020
Dec2018
Particulars
Jun 2023
Jun 2022
Jun 2021
Jun 2020
Dec 2018
Operational & Financial Ratios
Earnings Per Share (Rs)
138.23
115.98
106.51
153.06
61.29
CEPS(Rs)
155.16
132.29
124.60
170.80
74.01
DPS(Rs)
95.00
52.50
130.00
230.00
440.00
Book NAV/Share(Rs)
447.62
366.99
421.59
544.82
927.78
Tax Rate(%)
26.97
24.02
24.21
28.40
35.60
Margin Ratios
Core EBITDA Margin(%)
24.44
22.73
24.39
23.18
16.98
EBIT Margin(%)
23.71
21.55
23.21
26.17
18.61
Pre Tax Margin(%)
23.66
21.51
23.13
26.17
18.61
PAT Margin (%)
17.28
16.35
17.53
18.74
11.98
Cash Profit Margin (%)
19.39
18.64
20.50
20.91
14.47
Performance Ratios
ROA(%)
11.00
9.83
8.65
10.82
4.96
ROE(%)
33.94
29.41
22.04
20.79
8.95
ROCE(%)
46.07
38.45
29.08
29.01
13.90
Asset Turnover(x)
0.64
0.60
0.49
0.58
0.41
Sales/Fixed Asset(x)
5.27
5.17
4.87
7.04
4.50
Working Capital/Sales(x)
2.70
3.13
2.07
1.87
0.63
Efficiency Ratios
Fixed Capital/Sales(x)
0.19
0.19
0.21
0.14
0.22
Receivable days
27.36
22.20
28.06
21.73
40.59
Inventory Days
34.37
36.19
45.68
33.31
58.27
Payable days
206.35
188.51
177.09
90.99
116.16
Valuation Parameters
PER(x)
37.97
36.10
52.52
26.57
50.32
PCE(x)
33.83
31.65
44.89
23.81
41.67
Price/Book(x)
11.73
11.41
13.27
7.47
3.32
Yield(%)
1.81
1.25
2.32
5.65
14.27
EV/Net Sales(x)
6.73
5.95
8.74
4.51
4.57
EV/Core EBITDA(x)
24.12
23.59
33.38
15.91
22.47
EV/EBIT(x)
26.27
26.11
37.67
17.23
24.54
EV/CE(x)
3.71
3.42
4.46
2.89
1.50
M Cap / Sales
7.09
6.24
9.21
4.98
6.03
Growth Ratio
Net Sales Growth(%)
10.34
10.48
-25.60
59.70
21.61
Core EBITDA Growth(%)
22.15
6.34
-31.27
122.73
70.76
EBIT Growth(%)
24.11
8.42
-34.03
124.62
59.70
PAT Growth(%)
19.19
8.89
-30.42
149.73
66.68
EPS Growth(%)
19.19
8.89
-30.42
149.73
66.68
Financial Stability Ratios
Total Debt/Equity(x)
0.00
0.00
0.00
0.00
0.00
Current Ratio(x)
1.72
1.62
1.89
2.35
3.45
Quick Ratio(x)
1.53
1.43
1.67
2.10
3.24
Interest Cover(x)
409.05
604.26
292.60
NA
NA
Total Debt/Mcap(x)
0.00
0.00
0.00
0.00
0.00